
FUJIFILM Sonosite, Inc. Risk Report
Generated on July 16, 2025
1
Risks
Summary
โ๏ธ Legal & Regulatory
Fujifilm Sonosite has been involved in legal proceedings concerning intellectual property and industry classification. Patent disputes have been prominent, potentially impacting operations and finances, especially given the competitive ultrasound market dynamics.
- Fujifilm Sonosite faced legal inquiries on whether it qualifies as a manufacturer ๐ June 27, 2025.
- A patent infringement lawsuit was filed against Butterfly Network over handheld ultrasound technology ๐ March 10, 2022.
- An earlier patent infringement lawsuit against Butterfly Network was filed concerning POCUS patents ๐ March 8, 2022.
- Butterfly Network requested the dismissal of the Fujifilm Sonosite IP lawsuit ๐ August 9, 2022.
๐ Innovation & R&D
Fujifilm Sonosite continues to push the boundaries of ultrasound technology, focusing on integrating advanced features and expanding into new markets. Their commitment to AI integration is evident, suggesting notable potential for future growth and technological leadership.
- Fujifilm Sonosite started targeting India for the development of advanced technologies, including AI applications ๐ February 5, 2025.
- The company expanded its presence in India to bolster AI and technology innovation efforts ๐ February 5, 2025.
- A new VP was appointed to lead R&D, highlighting the focus on innovation ๐ October 11, 2023.
- Recent product introductions include the Sonosite LX premium ultrasound system ๐ February 15, 2022.
News & Media
Stay informed with real-time news signals across financial, legal, and operational domains.
Profile
Specialties
Anesthesia, Bedside ultrasound, Cardiology, Critical Care, Emergency Medicine, High-performance ultrasound, MSK, Medical devices, Nursing, Perioperative, Point-of-care ultrasound, Primary Care, Product training and clinical education, Ultra high-frequency micro-ultrasound, Vet